$MANH
Manhattan Associates Inc

2015 Q3 Form 10-Q Financial Statement

#000156459015008595 Filed on October 26, 2015

View on sec.gov

Income Statement

Concept 2015 Q3 2014 Q3
Revenue $142.3M $125.6M
YoY Change 13.29% 16.52%
Cost Of Revenue $58.10M $53.86M
YoY Change 7.86% 19.45%
Gross Profit $84.21M $71.74M
YoY Change 17.37% 14.41%
Gross Profit Margin 59.17% 57.12%
Selling, General & Admin $24.96M $22.33M
YoY Change 11.78% 13.83%
% of Gross Profit 29.64% 31.13%
Research & Development $13.59M $12.24M
YoY Change 11.06% 12.2%
% of Gross Profit 16.14% 17.06%
Depreciation & Amortization $2.000M $1.675M
YoY Change 19.4% 18.46%
% of Gross Profit 2.38% 2.33%
Operating Expenses $38.55M $34.57M
YoY Change 11.52% 13.25%
Operating Profit $43.68M $35.50M
YoY Change 23.04% 15.37%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $604.0K -$55.00K
YoY Change -1198.18% -110.07%
Pretax Income $44.28M $35.45M
YoY Change 24.93% 13.18%
Income Tax $16.39M $13.11M
% Of Pretax Income 37.0% 36.97%
Net Earnings $27.90M $22.34M
YoY Change 24.87% 13.47%
Net Earnings / Revenue 19.6% 17.79%
Basic Earnings Per Share $0.38 $0.30
Diluted Earnings Per Share $0.38 $0.30
COMMON SHARES
Basic Shares Outstanding 73.26M 74.69M
Diluted Shares Outstanding 73.76M 75.47M

Balance Sheet

Concept 2015 Q3 2014 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $119.1M $111.5M
YoY Change 6.82% -11.44%
Cash & Equivalents $109.0M $101.1M
Short-Term Investments $10.10M $10.40M
Other Short-Term Assets $20.50M $17.40M
YoY Change 17.82% 19.18%
Inventory
Prepaid Expenses
Receivables $92.00M $88.00M
Other Receivables $0.00 $0.00
Total Short-Term Assets $231.6M $216.9M
YoY Change 6.79% 3.91%
LONG-TERM ASSETS
Property, Plant & Equipment $21.40M $16.37M
YoY Change 30.73% 14.89%
Goodwill $62.26M
YoY Change -0.02%
Intangibles $2.907M
YoY Change
Long-Term Investments
YoY Change
Other Assets $7.500M $6.200M
YoY Change 20.97% 181.82%
Total Long-Term Assets $91.10M $87.75M
YoY Change 3.82% 11.44%
TOTAL ASSETS
Total Short-Term Assets $231.6M $216.9M
Total Long-Term Assets $91.10M $87.75M
Total Assets $322.7M $304.6M
YoY Change 5.94% 5.97%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $10.10M $10.22M
YoY Change -1.16% 20.22%
Accrued Expenses $37.20M $33.90M
YoY Change 9.73% 27.44%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $119.7M $106.8M
YoY Change 12.05% 7.04%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $12.70M $13.31M
YoY Change -4.59% 23.7%
Total Long-Term Liabilities $12.70M $13.31M
YoY Change -4.59% 23.7%
TOTAL LIABILITIES
Total Short-Term Liabilities $119.7M $106.8M
Total Long-Term Liabilities $12.70M $13.31M
Total Liabilities $132.4M $120.1M
YoY Change 10.21% 8.67%
SHAREHOLDERS EQUITY
Retained Earnings $191.9M
YoY Change 3.93%
Common Stock $746.0K
YoY Change 288.54%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $190.4M $184.5M
YoY Change
Total Liabilities & Shareholders Equity $322.7M $304.6M
YoY Change 5.94% 5.97%

Cashflow Statement

Concept 2015 Q3 2014 Q3
OPERATING ACTIVITIES
Net Income $27.90M $22.34M
YoY Change 24.87% 13.47%
Depreciation, Depletion And Amortization $2.000M $1.675M
YoY Change 19.4% 18.46%
Cash From Operating Activities $41.30M $32.70M
YoY Change 26.3% 0.0%
INVESTING ACTIVITIES
Capital Expenditures -$3.800M -$3.100M
YoY Change 22.58% 93.75%
Acquisitions
YoY Change
Other Investing Activities -$2.200M -$3.200M
YoY Change -31.25% 1500.0%
Cash From Investing Activities -$6.100M -$6.300M
YoY Change -3.17% 250.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -24.90M -14.70M
YoY Change 69.39% 32.43%
NET CHANGE
Cash From Operating Activities 41.30M 32.70M
Cash From Investing Activities -6.100M -6.300M
Cash From Financing Activities -24.90M -14.70M
Net Change In Cash 10.30M 11.70M
YoY Change -11.97% -40.91%
FREE CASH FLOW
Cash From Operating Activities $41.30M $32.70M
Capital Expenditures -$3.800M -$3.100M
Free Cash Flow $45.10M $35.80M
YoY Change 25.98% 4.37%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015Q3 us-gaap Sales Revenue Net
SalesRevenueNet
142304000
CY2014Q3 us-gaap Sales Revenue Net
SalesRevenueNet
125608000
CY2015Q3 manh Hardware Revenue And Other
HardwareRevenueAndOther
10625000
CY2014Q3 manh Hardware Revenue And Other
HardwareRevenueAndOther
10145000
CY2014Q3 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
98518000
us-gaap Licenses Revenue
LicensesRevenue
58202000
us-gaap Licenses Revenue
LicensesRevenue
52041000
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
321096000
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
278950000
manh Hardware Revenue And Other
HardwareRevenueAndOther
35638000
manh Hardware Revenue And Other
HardwareRevenueAndOther
30710000
us-gaap Sales Revenue Net
SalesRevenueNet
414936000
us-gaap Sales Revenue Net
SalesRevenueNet
361701000
us-gaap License Costs
LicenseCosts
7348000
us-gaap License Costs
LicenseCosts
5140000
us-gaap Cost Of Services
CostOfServices
137930000
us-gaap Cost Of Services
CostOfServices
123606000
manh Cost Of Hardware And Other
CostOfHardwareAndOther
29819000
manh Cost Of Hardware And Other
CostOfHardwareAndOther
25240000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
24000
CY2015Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
44284000
manh Tax Benefit Deficiency Of Stock Awards Exercised Vested
TaxBenefitDeficiencyOfStockAwardsExercisedVested
7395000
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
8413000
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
7359000
manh Increase Decrease In Accounts Payable And Accrued And Other Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedAndOtherLiabilities
1564000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-602000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
35906000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
40402000
CY2015Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1977000
CY2015Q3 us-gaap License Costs
LicenseCosts
2305000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
4652000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
73616000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
75255000
CY2015Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
73761000
us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
1825000
us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
1849000
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
27897000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
32761000
CY2014Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1675000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
5656000
CY2015Q3 us-gaap Costs And Expenses
CostsAndExpenses
98624000
CY2015Q3 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
112549000
CY2014Q3 manh Cost Of Hardware And Other
CostOfHardwareAndOther
8496000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
123143000
CY2014Q3 us-gaap License Costs
LicenseCosts
1679000
CY2015Q3 us-gaap Cost Of Services
CostOfServices
46682000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
36430000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
98076000
CY2015Q3 manh Cost Of Hardware And Other
CostOfHardwareAndOther
9109000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1225000
CY2015Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
16387000
us-gaap Operating Income Loss
OperatingIncomeLoss
98052000
CY2014Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13106000
CY2014Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
11476000
us-gaap Net Income Loss
NetIncomeLoss
77105000
CY2014Q3 us-gaap Costs And Expenses
CostsAndExpenses
90107000
CY2015Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13589000
CY2014Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12236000
CY2014Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
35501000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.05
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
46038000
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
22340000
us-gaap Costs And Expenses
CostsAndExpenses
263649000
CY2014Q3 us-gaap Cost Of Services
CostOfServices
43689000
us-gaap Net Income Loss
NetIncomeLoss
61646000
CY2015Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.38
CY2014Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
35446000
us-gaap Costs And Expenses
CostsAndExpenses
293018000
CY2015Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
10904000
CY2015Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
14058000
CY2014Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10856000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.82
CY2015Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
43680000
us-gaap Operating Income Loss
OperatingIncomeLoss
121918000
CY2015Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.38
CY2014Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.30
CY2015Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
604000
CY2014Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-55000
CY2014Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.30
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
36344000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
37223000
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
122000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
34640000
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
712000
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-86000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
38000
CY2014Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
75466000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
75087000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.04
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
74162000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
61226000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
76104000
CY2014Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1697000
CY2015Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1891000
manh Tax Benefit Deficiency Of Stock Awards Exercised Vested
TaxBenefitDeficiencyOfStockAwardsExercisedVested
8435000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2018000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-420000
CY2015Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
26006000
CY2014Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
20643000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.81
CY2015Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
73259000
CY2014Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
74687000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
4786000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9619000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6676000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
6651000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
86839000
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
36000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
6609000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
17147000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1592000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
6408000
manh Increase Decrease In Accounts Payable And Accrued And Other Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedAndOtherLiabilities
-8444000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
53717000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
84034000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
546000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.374
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.371
manh Amount Of Dilutive Securities Stock Options And Restrictive Stock Units Per Share
AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnitsPerShare
-0.01
CY2014Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
779000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
849000
us-gaap Reimbursement Revenue
ReimbursementRevenue
15400000
us-gaap Reimbursement Revenue
ReimbursementRevenue
13900000
CY2014Q3 us-gaap Restricted Stock Expense
RestrictedStockExpense
2300000
us-gaap Restricted Stock Expense
RestrictedStockExpense
11100000
us-gaap Restricted Stock Expense
RestrictedStockExpense
7000000
CY2014Q3 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
0
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
0
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
0
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
40412
CY2014Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.370
CY2015Q3 us-gaap Technology Services Revenue
TechnologyServicesRevenue
80994000
CY2014Q3 us-gaap Technology Services Revenue
TechnologyServicesRevenue
69398000
us-gaap Technology Services Revenue
TechnologyServicesRevenue
230201000
CY2015Q3 us-gaap Maintenance Revenue
MaintenanceRevenue
31555000
CY2014Q3 us-gaap Maintenance Revenue
MaintenanceRevenue
29120000
us-gaap Maintenance Revenue
MaintenanceRevenue
90895000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-2442000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
568000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
8413000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-77858000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-1411000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-6679000
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
124375000
CY2015Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
502000
CY2014Q3 us-gaap Reimbursement Revenue
ReimbursementRevenue
5400000
CY2015Q3 us-gaap Restricted Stock Expense
RestrictedStockExpense
5300000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
2773000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-11444000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-11298000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
73706000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1014000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
7359000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-65333000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-345000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-23259000
CY2014Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
101116000
CY2015Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.370
manh Amount Of Dilutive Securities Stock Options And Restrictive Stock Units Per Share
AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnitsPerShare
-0.01
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2015Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
38900000
CY2015Q3 us-gaap Long Term Investments
LongTermInvestments
0
CY2015Q3 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
0
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
153764
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
113352
CY2015Q3 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
200000
CY2015Q3 us-gaap Reimbursement Revenue
ReimbursementRevenue
5200000
CY2015Q3 us-gaap Cash
Cash
70100000
CY2014 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3
CY2015Q3 us-gaap Cost Of Revenue
CostOfRevenue
58096000
CY2014Q3 us-gaap Cost Of Revenue
CostOfRevenue
53864000
CY2015Q3 manh Operating Expenses Excluding Depreciation And Amortization
OperatingExpensesExcludingDepreciationAndAmortization
38551000
CY2014Q3 manh Operating Expenses Excluding Depreciation And Amortization
OperatingExpensesExcludingDepreciationAndAmortization
34568000
us-gaap Cost Of Revenue
CostOfRevenue
175097000
us-gaap Cost Of Revenue
CostOfRevenue
153986000
manh Operating Expenses Excluding Depreciation And Amortization
OperatingExpensesExcludingDepreciationAndAmortization
112265000
manh Operating Expenses Excluding Depreciation And Amortization
OperatingExpensesExcludingDepreciationAndAmortization
105011000
us-gaap Technology Services Revenue
TechnologyServicesRevenue
194522000
us-gaap Maintenance Revenue
MaintenanceRevenue
84428000

Files In Submission

Name View Source Status
0001564590-15-008595-index-headers.html Edgar Link pending
0001564590-15-008595-index.html Edgar Link pending
0001564590-15-008595.txt Edgar Link pending
0001564590-15-008595-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
manh-10q_20150930.htm Edgar Link pending
manh-20150930.xml Edgar Link completed
manh-20150930.xsd Edgar Link pending
manh-20150930_cal.xml Edgar Link unprocessable
manh-20150930_def.xml Edgar Link unprocessable
manh-20150930_lab.xml Edgar Link unprocessable
manh-20150930_pre.xml Edgar Link unprocessable
manh-ex311_8.htm Edgar Link pending
manh-ex312_6.htm Edgar Link pending
manh-ex32_9.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending